Inventor
WHITTEN KATHLEEN R
US25 patents
⚠️ This page may combine multiple inventors who share the name “WHITTEN KATHLEEN R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LILLY CO ELI
13 patentsUS4931447AJun 5, 1990
Cycloalkylamides of (8β)-1-alkyl-6-(substituted) ergolines
LILLY CO ELI16 citations73
US4762842AAug 9, 1988
Selective method for blocking 5HT2 receptors
LILLY CO ELI16 citations72
US4968802ANov 6, 1990
Process of making alkoxy cycloalkanol esters of dihydrolysergic acid
LILLY CO ELI3 citations62
US4914100AApr 3, 1990
Alkoxy cycloalkanol esters of dihydrolysergic acid
LILLY CO ELI2 citations62
US4714704ADec 22, 1987
Alkoxy cycloalkanol esters of dihydrolysergic acid useful as 5HT receptor antagonists
LILLY CO ELI6 citations62
US4810710AMar 7, 1989
4-hydroxycyclohexyl 1-isopropyl-9,10-dihydro-lysergate for the treatment of migraine
LILLY CO ELI3 citations61
US4713384ADec 15, 1987
Selective method for blocking 5HT2 receptors
LILLY CO ELI5 citations61
US4683236AJul 28, 1987
Cycloalkanol esters of dihydrolysergic acid useful as 5Ht2 receptor antagonists
LILLY CO ELI4 citations60
US4847261AJul 11, 1989
Alkoxy cycloalkanol esters of dihydrolysergic acid having peripheral serotonin antagonists properties
LILLY CO ELI1 citations51
US4704396ANov 3, 1987
Phenacyl esters of 1-substituted-6-(substituted and unsubstituted) dihydrolysergic acids useful as 5HT receptor antagonists
LILLY CO ELI0 citations51
US4939258AJul 3, 1990
Cycloalkanol esters of dihydrolysergic acid
LILLY CO ELI1 citations50
US4906639AMar 6, 1990
Cycloalkanol esters of dihydrolysergic acid
LILLY CO ELI1 citations50
US4845224AJul 4, 1989
Cycloalkanol esters of dihydrolysergic acid having peripheral serotonin antagonist properties
LILLY CO ELI0 citations50
AGOURON PHARMA
11 patentsUS5705647AJan 6, 1998
Intermediates for making HIV-protease inhibitors
AGOURON PHARMA24 citations91
US5962725AOct 5, 1999
Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir
AGOURON PHARMA14 citations81
US5925759AJul 20, 1999
Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
AGOURON PHARMA6 citations72
US6512135B2Jan 28, 2003
Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors
AGOURON PHARMA1 citations62
US6303786B1Oct 16, 2001
Processes for making nelfinavir mesylate
AGOURON PHARMA3 citations62
US6316625B1Nov 13, 2001
Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
AGOURON PHARMA1 citations61
US6084107AJul 4, 2000
Intermediates for making HIV-protease inhibitors
AGOURON PHARMA4 citations61
US6605721B2Aug 12, 2003
Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors
AGOURON PHARMA0 citations51
US6407285B1Jun 18, 2002
Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors
AGOURON PHARMA0 citations51
US6465661B1Oct 15, 2002
Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
AGOURON PHARMA0 citations50
US6392067B1May 21, 2002
Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
AGOURON PHARMA0 citations50